Search results for "Cardiac"

showing 10 items of 1495 documents

Central obesity and hypertension: Pathophysiologic role of renal haemodynamics and function

1995

OBJECTIVE: To investigate the role of alterations in renal haemodynamics and function and in plasma renin activity on obesity-induced hypertension. DESIGN: Renal haemodynamics and function, salt-regulating hormones and structural cardiac parameters were evaluated in 20 lean normotensives and in 64 obese subjects with central or peripheral fat distribution, 43 of them were normotensives and 21 of them were hypertensives. Obesity and central fat distribution were defined according to sex-specific 85th percentile respectively of Body Mass Index (BMI) and Waist to Hip Ratio (WHR). MEASUREMENTS: Serum immunoreactive insulin (IRI), plasma renin activity (PRA), plasma aldosterone (PA), microalbumi…

Settore MED/14 - NefrologiaAdultMaleSettore MED/09 - Medicina InternaSodiumHemodynamicsKidneySettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheBody Mass IndexBody fat distribution hypertension renal hemodynamics plasma renin activityHypertensionReninAlbuminuriaBody ConstitutionHumansInsulinFemaleVascular ResistanceObesityCardiac OutputAldosteroneGlomerular Filtration Rate
researchProduct

[OP.2D.05] RELATIONSHIP OF OXIDATIVE STRESS WITH CARDIAC HYPERTROPHY IN HYPERTENSIVE PATIENTS

2016

OBJECTIVE: Left ventricular hypertrophy is common in hypertensive patients. In these subjects increased oxidative stress has been observed. Our aim was to evaluate the association of biomarkers of both oxidative stress and inflammation with markers of cardiovascular damage in a large group of hypertensives with different stages of renal function. DESIGN AND METHOD: In 517 hypertensives we analyzed left ventricular mass indexed for body surface area, and we assayed plasma levels of 8-isoprostaglandin F2alpha and high sensitivity C reactive protein. RESULTS: Multivariate analysis carried out considering left ventricular mass as dependent variable, and including 8-isoprostaglandin F2alpha, hig…

Settore MED/14 - Nefrologiamedicine.medical_specialtySettore MED/09 - Medicina InternaPhysiologybusiness.industrymedicine.disease_causeLEFT VENTRICULAR HYPERTROPHY - ARTERIAL HYPERTENSION - OXIDATIVE STRESSSettore MED/11 - Malattie Dell'Apparato CardiovascolareCardiac hypertrophyInternal medicineInternal MedicinemedicineCardiologyCardiology and Cardiovascular MedicinebusinessOxidative stressJournal of Hypertension
researchProduct

RISOLUZIONE DI UN’ENDOCARDITE DA MRSA CON VEGETAZIONE LARGA, MOBILE E COMPLICATA DA STROKE EMBOLICO TRATTATA CON SOLA TERAPIA ANTIBIOTICA COMBINATA

2013

Settore MED/17 - Malattie InfettiveSettore MED/41 - AnestesiologiaSettore MED/23 - Chirurgia CardiacaEndocardite MRSA
researchProduct

DISTRIBUTION OF ESOPHAGEAL DYSMOTILITIES AMONG PATIENTS WITH NON-CARDIAC CHEST PAIN, DYSPHAGIA OR BOTH

2012

disphagia, non-cardiac chest pain

Settore MED/18 - Chirurgia GeneraleSettore MED/12 - Gastroenterologiadisphagia non-cardiac chest painSettore MED/45 - Scienze Infermieristiche Generali Cliniche E Pediatriche
researchProduct

SUPERIOR MESENTERIC ARTERY SYNDROME: CLINICAL, ENDOSCOPICAL AND RADIOLOGICAL CORRELATIONS ACCORDING TO A SINGLE-CENTER EXPERIENCE

2015

Background and aim: The superior mesenteric artery (SMA) syndrome is a rare entity presenting with upper gastrointestinal tract obstruction and weight loss, due to the compression of the third part of duodenum between the aorta and the SMA. Studies to determine the optimal methods of diagnosis and treatment are essential. This study aims to analyze the clinical presentation, the doagnosis and the management of this syndrome. Material and medthods: Over a 2-year (2013-2014), 8 cases of SMA syndrome (out of 2074 esophago-gastro-duodenoscopies, EGDS) were initially suspected through EGDS. Therefore, these patients performed computed tomography (CT) scan to confirm the diagnosis. Once the diagn…

Settore MED/18 - Chirurgia Generalesuperior mesenteric artery clinical radiologial endoscopical aspects.Settore MED/23 - Chirurgia Cardiaca
researchProduct

Evolution Of Moderate Chronic Ischemic Mitral Regurgitation In Patients Underwent Only Coronary Artery Surgery: Clinical And Echocardiographic Follow…

2008

Management of moderate chronic ischemic mitral valve regurgitation (oIMR) is still debated. Several authors favouring surgical treatment in combining with coronary artery bypass grafting (CABG) while others suggested conservative approach. However, evolution of moderate oIMR after only CABG is still unclear. Aim of this study was to evaluate prospectively, at rest and under exercise condition, the clinical outcomes and echocardiographic results of patients with moderate cIMR underwent onlv CABG.

Settore MED/23 - Chirurgia Cardiacaischemic mitral regurgitation
researchProduct

Imaging dell'amiloidosi cardiaca in Risonanza Magnetica: Case Report.

2016

Amyloidosis is a rare group of diseases characterized by the deposition of amyloid protein level of various tissues and organs, including myocardial tissue, with progressive evolution towards heart failure. We report the case of a 76-year-old male patient with dyspnoea and easy fatigue, whose picture of Magnetic resonance imaging enabled the diagnosis of cardiac amyloidosis.

Settore MED/36 - Diagnostica Per Immagini E Radioterapiaamiloidosi cardiaca risonanza magnetica
researchProduct

IPEREOSINOFILIA IN MALATTIA DI KAWASAKI: INDICE DI RISCHIO DI PATOLOGIA CARDIACA IN UNA CASISTICA PEDIATRICA SICILIANA

2019

La malattia di Kawasaki (MK) è una vasculite sistemica con possibile coinvolgimento cardiaco, coronarite e/o aneurismi coronarici (CAL), la cui diagnosi talora è resa complessa specie in forme atipiche e/o incomplete. Alcuni autori evidenziano il rilievo di eosinofilia >350/mm3, soprattutto in pazienti con resistenza alla terapia con immunoglobuline (IVIG). Infiltrato eosinofilo è stato documentato, inoltre, nelle coronarie di pazienti con CAL. Nel periodo 2015 -2018, presso la Clinica Pediatrica di Palermo, abbiamo studiato 17 bambini (13 M; 4 F; età: 5-146 mesi: Mediana: 24 mesi) con diagnosi di MK. 11/17 (65%; 8 M; 3 F) hanno avuto alterazioni cardiologiche; fra questi 7/11 (64%) con …

Settore MED/38 - Pediatria Generale E SpecialisticaIPEREOSINOFILIA MALATTIA DI KAWASAKI PATOLOGIA CARDIACA
researchProduct

SUDDEN UNEXPLAINED JUVENILE DEATH AND THE ROLE OF MEDICOLEGAL INVESTIGATION: UPDATE ON MOLECULAR AUTOPSY

2012

In the past few years, contributions of molecular biology assays to the investigation of sudden juvenile death have permitted to clarify some of the pathogenetic aspects of sud-den arrhythmic death, opening the way to preventive action on victims’ relatives. We reviewed literature on the genetics of sudden juvenile death, and on molecular biol-ogy assays performed on autoptic samples. Biological investigation permits the detection of genetic mutations underlying the suscep-tibility to sudden cardiac death of individuals with rare inherited forms of arrhythmia (Long QT Syndrome, Brugada Syndrome, Lev’s disease etc.) through the analysis of criti-cal sequences codifying for ion channel subuni…

Settore MED/43 - Medicina Legalemolecula autpsy sudden cardiac death
researchProduct

Effetti della Terapia con Sacubitril/Valsartan sulla Capacità di Esercizio dei pazienti con Scompenso Cardiaco a Frazione di Eiezione Ridotta (HFrEF)…

2021

Introduzione: La terapia con Sacubitril/Valsartan nei pazienti con scompenso cardiaco a frazione di eiezione ridotta (HFrEF) si è dimostrata superiore alla singola terapia con Enalapril nella riduzione del rischio di morte ed ospedalizzazione per scompenso cardiaco. Obiettivo del presente studio è stato quello di valutare, nei pazienti con HFrEF, gli effetti della terapia con sacubitril/valsartan sulla capacità di esercizio valutata mediante Test Cardiorespiratorio e l’eventuale correlazione con il grado di fibrosi miocardica valutata mediante Risonanza Magnetica Cardiaca (CMR). Metodi: E’ stato condotto uno studio osservazionale, prospettico. 134 pazienti ambulatoriali con HFrEF sono stati…

Settore MED/50 - Scienze Tecniche Mediche ApplicateScompenso Cardiaco a Frazione di Eiezione Ridotta (HFrEF) Sacubitril/Valsartan Test Cardiorespiratorio Risonanza magnetica Cardiaca.
researchProduct